BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1356675)

  • 1. Hormonal and immunological regulation of 2', 5'-oligoadenylate synthetase activity in human peripheral blood mononuclear cells.
    Miele ME; Vesell ES; Ehmann WC; Lipton A; Harvey H; Kan NC
    Clin Immunol Immunopathol; 1992 Nov; 65(2):183-92. PubMed ID: 1356675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome.
    Preble OT; Rook AH; Steis R; Silverman RH; Krause D; Quinnan GV; Masur H; Jacob J; Longo D; Gelmann EP
    J Infect Dis; 1985 Sep; 152(3):457-65. PubMed ID: 2993441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro induction of 2'-5' oligoadenylate synthetase by interferon-alpha in nodular non-Hodgkin's lymphoma and correlations with the clinical response.
    Ferbus D; Khosravi S; Dumont J; Billard C
    J Biol Regul Homeost Agents; 1990; 4(4):127-34. PubMed ID: 2096597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo effect of interleukin-2 on the 2',5'-oligoadenylate synthetase activity of peripheral mononuclear blood cells.
    Handgretinger R; Bruchelt G; Kimmig A; Lang P; Daurer B; Dopfer R; Treuner J; Niethammer D
    J Interferon Res; 1990 Feb; 10(1):75-82. PubMed ID: 2109781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytic 2',5'-oligoadenylate synthetase is insensitive to dsRNA and interferon stimulation in autoimmune BB rats.
    Bonnevie-Nielsen V; Husum G; Kristiansen K
    J Interferon Res; 1991 Dec; 11(6):351-6. PubMed ID: 1800583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome.
    Lau AS; Read SE; Williams BR
    J Clin Invest; 1988 Oct; 82(4):1415-21. PubMed ID: 2971677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals.
    Witt PL; Spear GT; Lindstrom MJ; Kessler HA; Borden EC; Phair J; Landay AL
    AIDS; 1991 Mar; 5(3):289-93. PubMed ID: 2059368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.
    Millar BC; Bell JB
    Br J Cancer; 1995 Dec; 72(6):1525-30. PubMed ID: 8519671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
    Ferbus D; Billard C; Sigaux F; Thang MN; Falcoff E
    J Biol Regul Homeost Agents; 1987; 1(3):147-53. PubMed ID: 2459906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
    Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
    J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of 2'5' oligo (A) synthetase in patients with metastatic renal cell carcinoma.
    Vakalikos J; Dimasis N; Peftulidis S; Galaktidou G; Kortsaris AH
    Int J Biol Markers; 1995; 10(2):113-4. PubMed ID: 7561235
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon alpha-2b and retinoic acid combined treatment affects proliferation and gene expression of human cervical carcinoma cells.
    Lancillotti F; Giandomenico V; Affabris E; Fiorucci G; Romeo G; Rossi GB
    Cancer Res; 1995 Jul; 55(14):3158-64. PubMed ID: 7606736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome.
    Suhadolnik RJ; Peterson DL; O'Brien K; Cheney PR; Herst CV; Reichenbach NL; Kon N; Horvath SE; Iacono KT; Adelson ME; De Meirleir K; De Becker P; Charubala R; Pfleiderer W
    J Interferon Cytokine Res; 1997 Jul; 17(7):377-85. PubMed ID: 9243369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C.
    Pawlotsky JM; Hovanessian A; Roudot-Thoraval F; Lebon P; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
    J Interferon Cytokine Res; 1995 Oct; 15(10):857-62. PubMed ID: 8564707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of 2',5'-oligoadenylate-dependent RNase expression in the human hepatoma cell line HepG2.
    Tnani M; Bayard BA
    Biochim Biophys Acta; 1998 Mar; 1402(2):139-50. PubMed ID: 9561800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha.
    Pawlotsky JM; Hovanessian AG; Roudot-Thoraval F; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D
    Antimicrob Agents Chemother; 1996 Feb; 40(2):320-4. PubMed ID: 8834873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients.
    Ogawa Y
    Gastroenterol Jpn; 1988 Jun; 23(3):279-86. PubMed ID: 2456963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of restoration of interferon production after bone marrow transplantation in man.
    Koscielniak E; Bruchelt G; Treuner J; Uchanska-Ziegler B; Dopfer R; Vallbracht A; Niethammer D
    Bone Marrow Transplant; 1987 Apr; 1(4):379-87. PubMed ID: 2458787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2',5'-oligoadenylate synthetase in interferon-alpha- and acyclovir-treated herpes simplex virus-infected cells.
    Taylor JL; Witt PL; Irizarry A; Tom P; O'Brien WJ
    J Interferon Cytokine Res; 1995 Jan; 15(1):27-30. PubMed ID: 7648430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
    Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
    Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.